Zivo BioscienceZIVO -27.08%14 Net Margin % is -1,565.15% as of Sep. 2025. GuruFocus rates ZIVO with a GF Score™ of 14/100. The stock has 5 warning signs investors should review. Among 947 Biotechnology companies, Zivo Bioscience ranks worse than 88.38% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Zivo Bioscience's Net Income for the
three
months ended in Sep. 2025 was $-1.03 Mil. Zivo Bioscience's Revenue for the
three
months ended in Sep. 2025 was $0.07 Mil. Therefore, Zivo Bioscience's net margin for the quarter that ended in Sep. 2025 was -1,565.15%.
The historical rank and industry rank for Zivo Bioscience's Net Margin % or its related term are showing as below:
ZIVO'
s Net Margin % Range Over the Past 10 Years
Min: -45530 Med: -27775 Max: -4059.81
Current: -4059.81
ZIVO's Net Margin % is ranked worse than 88.38% of 947
companies
in the Biotechnology industry
Industry Median: -89.33
vs ZIVO: -4059.81
Zivo Bioscience (OTCPK:ZIVO) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Zivo Bioscience Net Margin % Related Terms
Zivo Bioscience Net Margin % Historical Data
* Premium members only.
The historical data trend for Zivo Bioscience's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Zivo Bioscience's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zivo Bioscience Net Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zivo Bioscience's Net Margin % distribution charts can be found below:
* The bar in red indicates where Zivo Bioscience's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zivo Bioscience (ZIVO) has a Net Margin % of -1,565.15% as of Sep. 2025. Net margin is the ratio of total net income to net sales. View historical data on Zivo Bioscience and its competitors. According to the industry distribution chart, Zivo Bioscience ranks #837 out of 947 companies in the Biotechnology industry, placing it in the top 88.4%.
Is Zivo Bioscience's Net Margin % too high?
Zivo Bioscience's current Net Margin % is -1,565.15%. Based on the distribution chart, Zivo Bioscience ranks #837 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Zivo Bioscience has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Zivo Bioscience's Net Margin % compare to INAB and LPCN?
According to the Biotechnology industry distribution chart, Zivo Bioscience ranks #837 out of 947 companies for Net Margin %. This places Zivo Bioscience in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Zivo Bioscience and its competitors. Zivo Bioscience's current Net Margin % is -1,565.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zivo Bioscience stock overvalued right now?
Zivo Bioscience (ZIVO) has a current Net Margin % of -1,565.15%. The current Net Margin % is -1,565.15%. Zivo Bioscience's overall GF Score™ is 14/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Zivo Bioscience (ZIVO), the current Net Margin % is -1,565.15% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zivo Bioscience Inc operates in one reportable segment microalgae technology. The segment is research and development operating in both the therapeutic and nutritional sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's applications are ANIMAL APPLICATIONS, HUMAN APPLICATIONS.
14GF Score
Get the complete analysis for ZIVO
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZIVO has been successfully added to your 
